Herbalife Supplement

Herbalife Herbal Tea Concentrate

31 adverse event reports submitted to the FDA · 2007–2022 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 31 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Vomiting
6
Dyspnoea
6
Diarrhoea
4
Jaundice
3
Pruritus
3
Chest Pain
3
Nausea
3
Abdominal Pain
3
Constipation
3
Liver Function Test Abnormal
2

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

OutcomeReports
Hospitalization 26
Visited Emergency Room 10
Other Serious or Important Medical Event 8
Life Threatening 5
Other Serious Outcome 4
Visited a Health Care Provider 3
Required Intervention 1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18
1
18–34
9
35–49
8
50–64
5
65–79
3
80+
0
Unknown
5

26 reports had age data; 5 unknown.

Gender

Female
28
Male
3
Unknown/Not Reported
0

Reports by Year

Annual report counts from 2007–2022. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Hover bars for exact counts.

← View all Herbalife products in FDA data

Related Products

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗  ·  About our methodology  ·  How to read this data